
Rishi P Singh MD
Retinal Disease
Staff Physician and Chair of Ophthalmology, Mass Eye and Ear, Mass General Brigham
Join to view full profile
243 Charles StBoston, MA 02114
Phone+1 617-573-3288
Dr. Singh is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rishi Singh is an ophthalmologist based in Boston, MA, specializing in cataract-related conditions and retinal disease. He completed his medical education at Boston University School of Medicine in 2001 and his residency in ophthalmology at Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical School. Dr. Singh has been a staff physician at the Cleveland Clinic since 2007. His research experience includes hypertension, diabetes mellitus, diabetic retinopathy, diabetes, and vitreous detachment, with several publications in notable journals. Additionally, he has participated in multiple clinical trials related to retinal diseases and has received several CMS Meaningful Use Stage 2 Certifications from Epic Systems Corporation. He also serves as a Board Member At-Large for the American Society of Retina Specialists.
Education & Training
Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Ophthalmology, 2002 - 2005
Boston Medical Center-BrightonInternship, Transitional Year, 2001 - 2002
Boston University School of MedicineClass of 2001
Certifications & Licensure
FL State Medical License 2014 - 2026
MA State Medical License 2025 - 2026
OH State Medical License 2005 - 2026
MI State Medical License 2010 - 2014
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- The Impact of PCSK9 Inhibitors on Development of Retinal Vascular Occlusions.Isabella H Yazji, Nadia J Abbass, David C Kaelber, Katherine E Talcott, Rishi P Singh
American Journal of Ophthalmology. 2026-10-01 - Association of the Charlson Comorbidity Index With 1-Year Outcomes in Patients With Macular Edema Secondary to Retinal Vein Occlusion.Jonathan J Xavier, Hayden A Reed, Kanisha S Bahierathan, Sonia B Kim, Katherine E Talcott
American Journal of Ophthalmology. 2026-10-01 - 1 citationsComparative Endophthalmitis Rates in Adult and Pediatric Patients across Various Ophthalmic Procedures: An IRIS® Registry Analysis.Celine Chaaya, Eric A Goldberg, Connor J Ross, Yi Stephanie Zhang, Joseph D Fahey
Ophthalmology. 2026-09-01
Authored Content
- Advancing Insights into Diabetic Eye DiseaseAugust 2018
- Advancing Insights into Diabetic Eye DiseaseAugust 2018
Press Mentions
After Cleveland Clinic Expanded to Florida, Patients Say Surprise Fees FollowedJuly 24th, 2025
Port System Cuts Injection Burden in Diabetic Eye DiseaseMarch 11th, 2025
Cleveland Clinic Tradition Hospital Welcomes Three New CardiologistsFebruary 19th, 2025
Professional Memberships
- Fellow
External Links
- Websitehttp://www.drrishisingh.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









